Association of polymorphisms of SORBS1, GCK and WISP1 with hypertension in community-dwelling Japanese individuals

Hypertension Research

Volumn 32, Issue 5, 2009, Pages 325-331

  Yamada, Yoshiji ^a   Ando, Fujiko ^b,c   Shimokata, Hiroshi ^b  

^a MIE UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^c AICHI SHUKUTOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT SPECIFIC RECEPTOR; ALANINE; ALPHA ACTININ 3; ATP BINDING CASSETTE TRANSPORTER C8; BLOOD CLOTTING FACTOR 7; CARRIER PROTEINS AND BINDING PROTEINS; CHEMOKINE; CHEMOKINE CC LIGAND 2; COMPLEMENT FACTOR H; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 10; CYTOCHROME P450 1A2; DEIODINASE IODOTHYRONINE TYPE II; FETUIN A; GENE PRODUCT; GERANYLTRANSFERASE; GLUCOKINASE; GLUTATHIONE TRANSFERASE T1; IODOTHYRONINE; LEPTIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; PROTEIN TYROSINE PHOSPHATASE 1B; SOLUTE CARRIER FAMILY 6 MEMBER 2; SORBIN AND SH3 DOMAIN CONTAINING 1; THREONINE; THROMBOSPONDIN 2; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; WNT1 INDUCIBLE SIGNALING PATHWAY PROTEIN 1; WNT1 PROTEIN;

ADULT; AGED; AGING; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; COHORT ANALYSIS; COMMUNITY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HYPERTENSION; JAPAN; JAPANESE; LINKAGE ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; SITTING;

ADULT; AGE FACTORS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JAPAN; LONGITUDINAL STUDIES; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; POLYMORPHISM, GENETIC; PREVALENCE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; SEX FACTORS;

EID: 68249149370     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.23     Document Type: Article

References (37)

1. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104: 545-556.
2. Caulfield M, Munroe P, Pembroke J, Samani N, Dominiczak A, Brown M, Benjamin N, Webster J, Ratcliffe P, O'Shea S, Papp J, Taylor E, Dobson R, Knight J, Newhouse S, Hooper J, Loe W, Brain N, Clayton D, Lathrop GM, Farrall M, Connell J, MRC British Genetics of Hypertension Study. Genome-wide mapping of human loci for essential hypertension. Lancet 2003; 361: 2118-2123.
3. Gong M, Zhang H, Schulz H, Lee YA, Sun K, Bähring S, Luft FC, Nürnberg P, Reis A, Rohde K, Ganten D, Hui R, Hübner N. Genome-wide linkage reveals a locus for human essential (primary) hypertension on chromosome 12p. Hum Mol Genet 2003; 12: 1273-1277.
4. de Lange M, Spector TD, Andrew T. Genome-wide scan for blood pressure suggests linkage to chromosome 11, and replication of loci on 16, 17, and 22. Hypertension 2004; 44: 872-877.
5. Wallace C, Xue MZ, Newhouse SJ, Marcano AC, Onipinla AK, Burke B, Gungadoo J, Dobson RJ, Brown M, Connell JM, Dominiczak A, Lathrop GM, Webster J, Farrall M, Mein C, Samani NJ, Caulfield MJ, Clayton DG, Munroe PB. Linkage analysis using co-phenotypes in the BRIGHT study reveals novel potential susceptibility loci for hypertension. Am J Hum Genet 2006; 79: 323-331.
6. Yatsu K, Mizuki N, Hirawa N, Oka A, Itoh N, Yamane T, Ogawa M, Shiwa T, Tabara Y, Ohno S, Soma M, Hata A, Nakao K, Ueshima H, Ogihara T, Tomoike H, Miki T, Kimura A, Mano S, Kulski JK, Umemura S, Inoko H. High-resolution mapping for essential hypertension using microsatellite markers. Hypertension 2007; 49: 446-452.
7. Kato N, Miyata T, Tabara Y, Katsuya T, Yanai K, Hanada H, Kamide K, Nakura J, Kohara K, Takeuchi F, Mano H, Yasunami M, Kimura A, Kita Y, Ueshima H, Nakayama T, Soma M, Hata A, Fujioka A, Kawano Y, Nakao K, Sekine A, Yoshida T, Nakamura Y, Saruta T, Ogihara T, Sugano S, Miki T, Tomoike H. High-density association study and nomination of susceptibility genes for hypertension in the Japanese National Project. Hum Mol Genet 2008; 17: 617-627.
8. Cusi D, Barlassina C, Azzani T, Casari G, Citterio L, Devoto M, Glorioso N, Lanzani C, Manunta P, Righetti M, Rivera R, Stella P, Troffa C, Zagato L, Bianchi G. Polymorphisms of α-adducin and salt sensitivity in patients with essential hypertension. Lancet 1997; 349: 1353-1357.
9. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann HE, Jakobs KH, Horsthemke B. Association of a human G-protein β3 subunit variant with hypertension. Nat Genet 1998; 18: 45-48.
10. Izawa H, Yamada Y, Okada T, Tanaka M, Hirayama H, Yokota M. Prediction of genetic risk for hypertension. Hypertension 2003; 41: 1035-1040.
11. Yamada Y, Matsuo H, Segawa T, Watanabe S, Kato K, Hibino T, Yokoi K, Ichihara S, Metoki N, Yoshida H, Satoh K, Nozawa Y. Assessment of the genetic component of hypertension. Am J Hypertens 2006; 19: 1158-1165.
12. Kohara K, Tabara Y, Nakura J, Imai Y, Ohkubo T, Hata A, Soma M, Nakayama T, Umemura S, Hirawa N, Ueshima H, Kita Y, Ogihara T, Katsuya T, Takahashi N, Tokunaga K, Miki T. Identification of hypertension-susceptibility genes and pathways by a systemic multiple candidate gene approach: The millennium genome project for hypertension. Hypertens Res 2008; 31: 203-212.
13. Lin WH, Chiu KC, Chang HM, Lee KC, Tai TY, Chuang LM. Molecular scanning of the human sorbin and SH3-domain-containing-1 (SORBS1) gene: Positive association of the T228A polymorphism with obesity and type 2 diabetes. Hum Mol Genet 2001; 10: 1753-1760.
14. Stone LM, Kahn SE, Fujimoto WY, Deeb SS, Porte Jr D. A variation at position -30 of the beta-cell glucokinase gene promoter is associated with reduced beta-cell function in middle-aged Japanese-American men. Diabetes 1996; 45: 422-428.
15. Urano T, Narusawa K, Shiraki M, Usui T, Sasaki N, Hosoi T, Ouchi Y, Nakamura T, Inoue S. Association of a single nucleotide polymorphism in the WISP1 gene with spinal osteoarthritis in postmenopausal Japanese women. J Bone Miner Metab 2007; 25: 253-258.
16. Shimokata H, Ando F, Niino N. A new comprehensive study on aging - the National Institute for Longevity Sciences, Longitudinal Study of Aging (NILS-LSA). J Epidemiol 2000; 10: S1-S9.
17. Yamada Y, Ando F, Niino N, Shimokata H. Association of polymorphisms of androgen receptor and klotho genes with bone mineral density in Japanese women. J Mol Med 2005; 83: 50-57.
18. Yamada Y, Ando F, Shimokata H. Association of a microsomal triglyceride transfer protein gene polymorphism with blood pressure in Japanese women. Int J Mol Med 2006; 17: 83-88.
19. Yamada Y, Ando F, Shimokata H. Association of gene polymorphisms with blood pressure and the prevalence of hypertension in community-dwelling Japanese individuals. Int J Mol Med 2007; 19: 675-683.
20. Perloff D, Grim C, Flack J, Frohlich ED, Hill M, McDonald M, Morgenstern BZ. Human blood pressure determination by sphygmomanometry. Circulation 1993; 88: 2460-2470.
21. Hanley JA, Negassa A, Edwardes MO, Forrester JE. Statistical analysis of correlated data using generalized estimating equations: An orientation. Am J Epidemiol 2003; 157: 364-375.
22. Ten Have TR, Morabia A. Mixed effects models with bivariate and univariate association parameters for longitudinal bivariate binary response data. Biometrics 1999; 55: 85-93.
23. Lalouel J-M, Rohrwasser A. Development of genetic hypotheses in essential hypertension. J Hum Genet 2001; 46: 299-306.
24. Lin WH, Huang CJ, Liu MW, Chang HM, Chen YJ, Tai TY, Chuang LM. Cloning, mapping, and characterization of the human sorbin and SH3 domain containing 1 (SORBS1) gene: A protein associated with c-Abl during insulin signaling in the hepatoma cell line Hep3B. Genomics 2001; 74: 12-20.
25. Ribon V, Herrera R, Kay BK, Saltiel AR. A role for CAP, a novel, multifunctional Src homology 3 domain-containing protein in formation of actin stress fibers and focal adhesions. J Biol Chem 1998; 273 4073-4080.
26. Ribon V, Printen JA, Hoffman NG, Kay BK, Saltiel AR. A novel, multifunctional c-Cbl binding protein in insulin receptor signaling in 3T3-L1 adipocytes. Mol Cell Biol 1998; 18: 872-879.
27. Baumann CA, Ribon V, Kanzaki M, Thurmond DC, Mora S, Shigematsu S, Bickel PE, Pessin JE, Saltiel AR. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 2000; 407: 202-207.
28. Hagiwara N, Kitazono T, Kamouchi M, Kuroda J, Ago T, Hata J, Ninomiya T, Ooboshi H, Kumai Y, Yoshimura S, Tamaki K, Fujii K, Nagao T, Okada Y, Toyoda K, Nakane H, Sugimori H, Yamashita Y, Wakugawa Y, Kubo M, Tanizaki Y, Kiyohara Y, Ibayashi S, Iida M, Fukuoka Stroke Registry; Hisayama Study. Polymorphism in the sorbin and SH3-domain-containing-1 (SORBS1) gene and the risk of brain infarction in the Japanese population: The Fukuoka Stroke Registry and the Hisayama study. Eur J Neurol 2008; 15: 481-486.
29. Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, Moates JM, Shelton KD, Lindner J, Cherrington AD, Magnuson MA. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic β cell-specific gene knock-outs using Cre recombinase. J Biol Chem 1999; 274: 305-315.
30. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001; 345: 971-980.
31. Yamada K, Yuan X, Ishiyama S, Ichikawa F, Koyama KI, Koyanagi A, Koyama W, Nonaka K. Clinical characteristics of Japanese men with glucokinase gene beta-cell promoter variant. Diabetes Care 1997; 20: 1159-1161.
32. Marz W, Nauck M, Hoffmann MM, Nagel D, Boehm BO, Koenig W, Rothenbacher D, Winkelmann BR. G(-30)A polymorphism in the pancreatic promoter of the glucokinase gene associated with angiographic coronary artery disease and type 2 diabetes mellitus. Circulation 2004; 109: 2844-2849.
33. Chiang FT, Chiu KC, Tseng YZ, Lee KC, Chuang LM. Nucleotide(-258) G-to-A transition variant of the liver glucokinase gene is associated with essential hypertension. Am J Hypertens 1997; 10: 1049-1052.
34. Tanaka S, Sugimachi K, Saeki H, Kinoshita J, Ohga T, Shimada M, Maehara Y, Sugimachi K. A novel variant of WISP1 lacking a von Willebrand type C module overexpressed in scirrhous gastric carcinoma. Oncogene 2001; 20: 5525-5532.
35. Pennica D, Swanson TA, Welsh JW, Roy MA, Lawrence DA, Lee J, Brush J, Taneyhill LA, Deuel B, Lew M, Watanabe C, Cohen RL, Melhem MF, Finley GG, Quirke P, Goddard AD, Hillan KJ, Gurney AL, Botstein D, Levine AJ. WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci USA 1998; 95: 14717-14722.
36. Xu L, Corcoran RB, Welsh JW, Pennica D, Levine AJ. WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene. Genes Dev 2000; 14: 585-595.
37. Desnoyers L, Arnott D, Pennica D. WISP-1 binds to decorin and biglycan. J Biol Chem 2001; 276: 47599-47607.